These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 6756879)

  • 1. The new insulins. Their characteristics and clinical indications.
    Home PD; Alberti KG
    Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenicity of new insulins.
    Deckert T
    Diabetes; 1985 Jun; 34 Suppl 2():94-6. PubMed ID: 3888748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and allergenic potential of animal and human insulins.
    Schernthaner G
    Diabetes Care; 1993 Dec; 16 Suppl 3():155-65. PubMed ID: 8299472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
    Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
    Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic allergy to human (recombinant DNA) insulin.
    Gossain VV; Rovner DR; Mohan K
    Ann Allergy; 1985 Aug; 55(2):116-8. PubMed ID: 3896050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic insulin urticaria. Therapeutic efficacy and good tolerability of human insulins].
    Mirouze J; Monnier L; Rodier M; Balducchi JP; Orsetti A; Clot J
    Nouv Presse Med; 1982 Oct; 11(42):3121-4. PubMed ID: 6757860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of human insulin in cases of insulin allergy].
    Gerö L; Kerényi Z; Bányai Z; Tamás G
    Orv Hetil; 1989 May; 130(22):1159-62. PubMed ID: 2668841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential response to infusions of highly purified and conventional bovine and porcine insulins.
    Nosadini R; Noy G; Kurtz AB; Alberti KG
    Diabetes; 1981 Aug; 30(8):650-5. PubMed ID: 7018969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis and immunologic insulin resistance in a diabetic woman with ketoacidosis.
    Ross JM; Murali MR; DeLara TC; Cheron RG
    Diabetes Care; 1984; 7(3):276-9. PubMed ID: 6428840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin antibodies in the maternal and foetal circulation of pregnant diabetic women treated with human insulin of recombinant DNA origin.
    Leiper JM; Fineberg SE; Lunan CB; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):75-81. PubMed ID: 6397289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic pregnant women with monocomponent insulins.
    Gargiulo P; Di Mario U; Zuccarini O; Troili F; Tiberti C; Nicolini U; Pachi A; Gerlini G; Fallucca F
    Acta Endocrinol Suppl (Copenh); 1986; 277():60-5. PubMed ID: 3532672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
    Wilson RM; Douglas CA; Tattersall RB; Reeves WG
    Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.